{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:26:09Z","timestamp":1781839569601,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10096-019-03759-w","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T11:03:02Z","timestamp":1574938982000},"page":"569-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-1343","authenticated-orcid":false,"given":"Neven","family":"Papi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabijan","family":"Jelov\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Karlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna Stemberger","family":"Mari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Vince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"issue":"13","key":"3759_CR1","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated I, Antimicrobial Use Prevalence Survey T (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198\u20131208. https:\/\/doi.org\/10.1056\/NEJMoa1306801","journal-title":"N Engl J Med"},{"key":"3759_CR2","doi-asserted-by":"publisher","unstructured":"Crobach MJT, Vernon JJ, Loo VG, Kong LY, Pechine S, Wilcox MH, Kuijper EJ (2018) Understanding Clostridium difficile colonization. Clin Microbiol Rev 31(2). https:\/\/doi.org\/10.1128\/CMR.00021-17","DOI":"10.1128\/CMR.00021-17"},{"issue":"7","key":"3759_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","volume":"38","author":"J Czepiel","year":"2019","unstructured":"Czepiel J, Drozdz M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultanska D, Garlicki A, Biesiada G (2019) Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis 38(7):1211\u20131221. https:\/\/doi.org\/10.1007\/s10096-019-03539-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"3759_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1017\/S0950268818001036","volume":"146","author":"KM Dotson","year":"2018","unstructured":"Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW (2018) Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect 146(9):1101\u20131105. https:\/\/doi.org\/10.1017\/S0950268818001036","journal-title":"Epidemiol Infect"},{"issue":"10","key":"3759_CR5","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1099\/jmm.0.000596","volume":"66","author":"D Yan","year":"2017","unstructured":"Yan D, Chen Y, Lv T, Huang Y, Yang J, Li Y, Huang J, Li L (2017) Clostridium difficile colonization and infection in patients with hepatic cirrhosis. J Med Microbiol 66(10):1483\u20131488. https:\/\/doi.org\/10.1099\/jmm.0.000596","journal-title":"J Med Microbiol"},{"issue":"1","key":"3759_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"6","key":"3759_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the L","year":"2016","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O (2016) EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64(6):1388\u20131402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol"},{"issue":"2","key":"3759_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cgh.2018.08.065","volume":"17","author":"SR Sharpton","year":"2019","unstructured":"Sharpton SR, Ajmera V, Loomba R (2019) Emerging role of the gut microbiome in nonalcoholic fatty liver disease: from composition to function. Clin Gastroenterol Hepatol 17(2):296\u2013306. https:\/\/doi.org\/10.1016\/j.cgh.2018.08.065","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"3759_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/apt.15314","volume":"50","author":"S Jayakumar","year":"2019","unstructured":"Jayakumar S, Loomba R (2019) Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Aliment Pharmacol Ther 50(2):144\u2013158. https:\/\/doi.org\/10.1111\/apt.15314","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3759_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cardenas E, Sanchez-Avila F, Vargas-Vorackova F (2008) AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 7(4):350\u2013357","journal-title":"Ann Hepatol"},{"key":"3759_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"12","author":"Y Sumida","year":"2012","unstructured":"Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T, Japan Study Group of Nonalcoholic Fatty Liver D (2012) Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol 12:2. https:\/\/doi.org\/10.1186\/1471-230X-12-2","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"3759_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"Suppl 4","key":"3759_CR13","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","volume":"22","author":"MJ Crobach","year":"2016","unstructured":"Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ (2016) European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63\u2013S81. https:\/\/doi.org\/10.1016\/j.cmi.2016.03.010","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"3759_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66(7):e1\u2013e48. https:\/\/doi.org\/10.1093\/cid\/cix1085","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3759_CR15","first-page":"386","volume":"21","author":"W Nseir","year":"2019","unstructured":"Nseir W, Amara A, Farah R, Ahmad HS, Mograbi J, Mahamid M (2019) Non-alcoholic fatty liver disease is associated with recurrent urinary tract infection in premenopausal women independent of metabolic syndrome. Isr Med Assoc J 21(6):386\u2013389","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"3759_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.dld.2015.10.004","volume":"48","author":"W Nseir","year":"2016","unstructured":"Nseir W, Artul S, Nasrallah N, Mahamid M (2016) The association between primary bacteremia of presumed gastrointestinal origin and nonalcoholic fatty liver disease. Dig Liver Dis 48(3):343\u2013344. https:\/\/doi.org\/10.1016\/j.dld.2015.10.004","journal-title":"Dig Liver Dis"},{"issue":"2","key":"3759_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","volume":"112","author":"WB Nseir","year":"2019","unstructured":"Nseir WB, Mograbi JM, Amara AE, Abu Elheja OH, Mahamid MN (2019) Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia. QJM 112(2):95\u201399. https:\/\/doi.org\/10.1093\/qjmed\/hcy227","journal-title":"QJM"},{"issue":"4","key":"3759_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/MIB.0000000000001057","volume":"23","author":"G Kistangari","year":"2017","unstructured":"Kistangari G, Lopez R, Shen B (2017) Frequency and risk factors of Clostridium difficile infection in hospitalized patients with pouchitis: a population-based study. Inflamm Bowel Dis 23(4):661\u2013671. https:\/\/doi.org\/10.1097\/MIB.0000000000001057","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"3759_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajic.2010.08.017","volume":"39","author":"R Shakov","year":"2011","unstructured":"Shakov R, Salazar RS, Kagunye SK, Baddoura WJ, DeBari VA (2011) Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting. Am J Infect Control 39(3):194\u2013198. https:\/\/doi.org\/10.1016\/j.ajic.2010.08.017","journal-title":"Am J Infect Control"},{"issue":"1","key":"3759_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1503\/cmaj.1040876","volume":"171","author":"S Dial","year":"2004","unstructured":"Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D (2004) Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 171(1):33\u201338","journal-title":"CMAJ"},{"issue":"9","key":"3759_CR21","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s10620-018-5108-2","volume":"63","author":"S Chandradas","year":"2018","unstructured":"Chandradas S, Khalili H, Ananthakrishnan A, Wayman C, Reidel W, Waalen J, Konijeti GG (2018) Does obesity influence the risk of Clostridium difficile infection among patients with ulcerative colitis? Dig Dis Sci 63(9):2445\u20132450. https:\/\/doi.org\/10.1007\/s10620-018-5108-2","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3759_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/cid\/cit280","volume":"57","author":"J Bishara","year":"2013","unstructured":"Bishara J, Farah R, Mograbi J, Khalaila W, Abu-Elheja O, Mahamid M, Nseir W (2013) Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis 57(4):489\u2013493. https:\/\/doi.org\/10.1093\/cid\/cit280","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3759_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/apt.13832","volume":"45","author":"R Mulki","year":"2017","unstructured":"Mulki R, Baumann AJ, Alnabelsi T, Sandhu N, Alhamshari Y, Wheeler DS, Perloff S, Katz PO (2017) Body mass index greater than 35 is associated with severe Clostridium difficile infection. Aliment Pharmacol Ther 45(1):75\u201381. https:\/\/doi.org\/10.1111\/apt.13832","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"3759_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1099\/0022-1317-51-5-448","volume":"51","author":"MJ Hopkins","year":"2002","unstructured":"Hopkins MJ, Macfarlane GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51(5):448\u2013454. https:\/\/doi.org\/10.1099\/0022-1317-51-5-448","journal-title":"J Med Microbiol"},{"issue":"3","key":"3759_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Cales P, Diehl AM (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63(3):764\u2013775. https:\/\/doi.org\/10.1002\/hep.28356","journal-title":"Hepatology"},{"issue":"2","key":"3759_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/cid\/ciy484","volume":"68","author":"KM Mullane","year":"2019","unstructured":"Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS (2019) A randomized, placebo-controlled trial of fidaxomicin for prophylaxis of Clostridium difficile-associated diarrhea in adults undergoing hematopoietic stem cell transplantation. Clin Infect Dis 68(2):196\u2013203. https:\/\/doi.org\/10.1093\/cid\/ciy484","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3759_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/23744235.2018.1425551","volume":"50","author":"N Papic","year":"2018","unstructured":"Papic N, Maric LS, Vince A (2018) Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy. Infect Dis (Lond) 50(6):483\u2013486. https:\/\/doi.org\/10.1080\/23744235.2018.1425551","journal-title":"Infect Dis (Lond)"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03759-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:22:27Z","timestamp":1606436547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03759-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3759"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03759-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethical committee (Ethical committee University Hospital for Infectious Diseases Zagreb) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}